Where DNA Copying Fails Can Decide How Cancer Cells Respond to PARP Inhibitors

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 06 Nov, 03:46 UTC

NYU Grossman School of Medicine researchers found that DNA-copying problems at a small set of chromosome sites can determine how cancer cells respond to PARP inhibitors, pointing to possible biomarkers of drug sensitivity. The post Where DNA Copying Fails Can Decide How Cancer Cells Respond to PARP…

science

Sources

• T2Where DNA Copying Fails Can Decide How Cancer Cells Respond to PARP InhibitorsFierce Biotech / Fierce Healthcare / MedCity / GEN06 Nov, 03:46